Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
The current price of Pfizer Inc in the market is 25.67 US$, with a 24-hour trading volume of 609.07M US$. The asset's market cap is 146.33B US$, after moving -1.09% in the last day.
Tokenized Pfizer Inc is trading at 27.11 US$, with a tokenized market cap of 18.97M US$ and a 24-hour trading volume of 774.05K US$. The tokenized asset has moved -0.93% in the past 24 hours.